重組人TNFRSF14蛋白-細(xì)胞/細(xì)菌培養(yǎng)-試劑-生物在線

女人与狗锁死了视频大全|霍金死亡过程恐怖视频|无节社团简谱季免费观看|六间房直播大厅|中文字幕欧美另类精品|久久人人玩人妻潮喷内射人人|亚洲国产一区二区三区在线观看

蘇州近岸蛋白質(zhì)科技股份有限公司
重組人TNFRSF14蛋白

重組人TNFRSF14蛋白

商家詢價(jià)

產(chǎn)品名稱： 重組人TNFRSF14蛋白

英文名稱：

產(chǎn)品編號(hào)： C418

產(chǎn)品價(jià)格： 0

產(chǎn)品產(chǎn)地： 上海

品牌商標(biāo)： novoprotein

更新時(shí)間： null

使用范圍： null

蘇州近岸蛋白質(zhì)科技股份有限公司
  • 聯(lián)系人 : 蘇州近岸蛋白質(zhì)科技股份有限公司
  • 地址 : 上海市浦東新區(qū)伽利略路11號(hào)
  • 郵編 : 201203
  • 所在區(qū)域 : 江蘇
  • 電話 : 177****8253 點(diǎn)擊查看
  • 傳真 : 點(diǎn)擊查看
  • 郵箱 : product@novoprotein.com.cn
  • 二維碼 : 點(diǎn)擊查看


    
        

            目錄號(hào) 
            規(guī)格 
            價(jià)格 
            說明書下載 
        

        

            C418A
            2μg
            400元
            
        

        

            C418B
            10μg
            1800元
        

        

            C418C
            50μg
            4500元
        

    



?


TNFRSF14, also known as Herpesvirus entry  mediator (HVEM), TR2 (TNF receptor like molecule) and ATAR (another TRAF  associated receptor), is a type I membrane protein belonging to the  TNF/NGF receptor superfamily. The extracellular domain of HVEM contains  several cysteine rich repeats characteristic of TNF receptor superfamily  members. The short cytoplasmic region lacks a death domain present in  some TNF receptor family members, but contains a TRAF (TNF receptor  associated factor) interaction domain. The extracellular domain of HVEM  has been shown to interact directly with the herpes simplex virus(HSV)  envelope glycoprotein D which plays an important role in HSV  pathogenesis. Two TNF superfamily ligands, including the secreted TNFβ  (lymphotoxin α) and the membrane protein LIGHT competes with HSV  glycoprotein D for HVEM.The cytoplasmic region of HVEM was found to bind  to several TRAF family members, which may mediate the signal  transduction pathways that activate the immune response




·Description

Recombinant Human TNFRSF14 produced by  transiently transfected human cell is the extracellular  domain(Accession#Q92956) (Leu39-Val202) of human TNFRSF14 fused with a  polyhistidine tag at the C-terminus.




·Quality Control


Biological activity:The ED50 of  rHuTNFRSF14 is typically 2.5-10μg/mL in the presence of 1 ng/mL of  rhTNF?, as measured by its ability to inhibit TNF? mediated cytotoxicity  using L929 mouse fibrosarcoma cells.


Purity: Greater than 90.0% as determined by: 

(a) Analysis by RP-HPLC. 

(b) Analysis by reducing and non-reducing SDS-PAGE Silver Stained gel. 

Amino-Acid Sequence: Predicted N terminal amino acid is Leu39.


Endotoxin:Less than 0.1ng/μg (1EU/μg) of rHuTNFRSF14.


?


·Formulation

Sterile and Lyophilized from a 0.2 μm filtered solution in PBS.


·Reconstitution

It is recommended to reconstitute the  lyophilized rHuTNFRSF14 in sterile water not less than 100μg/ml, which  can then be further diluted to other aqueous solutions.


·Storage 

Lyophilized rHuTNFRSF14 although stable at  room temperature for 3 weeks, should be stored desiccated below -18°C.  Upon reconstitution rHuTNFRSF14 should be stored at 4°C between 2-7 days  and aliquots of reconstituted samples containing 0.1% BSA are stable up  to 3 months below -18°C for future use.